CryoLife (CRY) PT Raised to $39 at Needham & Company

July 30, 2021 6:30 AM EDT Send to a Friend
Needham & Company analyst Matt Matson raised the price target on CryoLife (NYSE: CRY) to $39.00 (from $38.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login